Skip to Content

WPI 3496 (Galantamine Hydrobromide Extended Release 8 mg)

Pill with imprint WPI 3496 is White, Capsule-shape and has been identified as Galantamine Hydrobromide Extended Release 8 mg. It is supplied by Watson Pharmaceuticals.

Galantamine is used in the treatment of alzheimer's disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Galantamine 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3496

Galantamine Hydrobromide Extended Release

Imprint
WPI 3496
Strength
8 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3496
Inactive Ingredients
magnesium stearate, silicon dioxide, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.